Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678899 · ClinicalTrials.gov registry record · NA
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
A NA study of Sensorineural Hearing Loss, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00678899: Completed NA study of Sensorineural Hearing Loss, sponsored by Cochlear.
NCT00678899 is a NA study of Sensorineural Hearing Loss that has completed, run by Cochlear. The registered enrollment target is 50 participants, below the 127-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00678899, a NA study of Sensorineural Hearing Loss, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus Hybrid L24 cochlear implant system.
Primary Outcome
The co-primary study endpoints will be statistically significant differences between the mean, preoperative monosyllabic CNC word score (unilateral acoustic, ear to be implanted) and the postoperative monosyllabic CNC word scores (Hybrid mode) for the activated, Hybrid L24 cochlear implant subjects. The CNC Words test consists of 10 recorded lists of 50 monosyllabic words in CD format. For this study, two lists will be administered in quiet at a level equal to 60 dBA in the sound field and scor
Conditions Studied
Interventions
- DEVICE Nucleus Hybrid L24
Study Locations (1)
New York
- NYU Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-04 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT00678899 record still lists
NCT00678899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 127-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Nucleus Hybrid L24 is the first listed.
NCT00678899 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00678899 about?
NCT00678899 is a clinical study titled "Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System". The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acous...
What is the current status of trial NCT00678899?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-04. Estimated completion is 2014-07.
What conditions does trial NCT00678899 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss.
What interventions are being tested in trial NCT00678899?
The interventions under investigation include: Nucleus Hybrid L24 (DEVICE).
Who is sponsoring clinical trial NCT00678899?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00678899 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00678899's enrollment target sits among peer trials
50 8th of 13 higher than 6 of 13 other Sensorineural Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
RECRUITING · NA
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
The Effect of Sound Stimulation on Pure-tone Hearing Threshold
COMPLETED · NA
-
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia